Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris

Immunology

Volumn 99, Issue 1, 2000, Pages 46-53

  Quigg, R J ^a   He, C ^a   Hack, B K ^a   Alexander, J J ^a   Morgan, B P ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ARTICLE; COMPLEMENT ACTIVATION; HEMOLYSIS; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION, SYNTHESIS AND MODIFICATION; PROTEIN PURIFICATION; RAT;

ANIMALS; ANTIGENS, CD59; ANTIGENS, SURFACE; COMPLEMENT INACTIVATOR PROTEINS; FERMENTATION; HEMOLYSIS; IMMUNOBLOTTING; PICHIA; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, COMPLEMENT; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS;

EID: 0033984831     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00945.x     Document Type: Article

References (41)

1. 1. Holers V.M. (1995) Complement. In: Principles and Practices of Clinical Immunology (ed. R. Rich), p. 363. Mosby, St. Louis, MO.
2. 2. Quigg R.J. (1991) Glomerular injury induced by antibody and complement. Sem Nephrol 11, 259.
3. 3. Campbell R.D., Law S.K.A., Reid K.B.M. & Sim R.B. (1988) Structure, organization, and regulation of the complement genes. Annu Rev Immunol 6, 161.
4. 4. Janatova J., Reid K.B. & Willis A.C. (1989) Disulfide bonds are localized within the short consensus repeat units of complement regulatory proteins: C4b-binding protein. Biochemistry 28, 4754.
5. 5. Morgan B.P. & Meri S. (1994) Membrane proteins that protect against complement lysis Springer Sem Immunopathol 15, 369.
6. 6. Wong W. & Fearon D.T. (1985) p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J Immunol 134, 4048.
7. 7. Paul M.S., Aegerter M., O'Brien S.E., Kurtz C.B. & Weis J.H. (1989) The murine complement receptor gene family. I. Analysis of mCRY gene products and their homology to human CR1. J Immunol 142, 582.
8. 8. Li B., Sallee C., Dehoff M., Foley S., Molina H. & Holers V.M. (1993) Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151, 4295.
9. 9. Funabashi K., Okada N., Matsuo S., Yamamoto T., Morgan B.P. & Okada H. (1994) Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81, 444.
10. 10. Hinchliffe S.J., Spiller O.B., Rushmere N.K. & Morgan B.P. (1998) Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor. J Immunol 161, 5695.
11. 11. Rushmere N.K., Van Den Berg C.W., Harrison R.A. & Morgan B.P. (1994) Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem J 304, 595.
12. 12. Vanden Berg C.W. & Morgan B.P. (1994) Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 152, 4095.
13. 13. Kalli K.R., Hsu P. & Fearon D.T. (1994) Therapeutic uses of recombinant complement protein inhibitors. Springer Sem Immunopathol 15, 417.
14. 14. Fodor W.L., Rollins S.A., Guilmette E.R., Setter E. & Squinto S.P. (1995) A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex. J Immunol 155, 4135.
15. 15. Higgins P.J., Jone-Long K., Lobell R., Sardonini C., Alessi M.K. & Yeh C.G. (1997) A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J Immunol 158, 2872.
16. 16. McCurry K.R., Kooyman D.L., Alvarado C.G. et al. (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts From humoral injury. Nature Med 1, 423.
17. 17. Kooyman D.L., Byrne G.W., McClellan S. et al. (1995) In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269, 89.
18. 18. Nangaku M., Quigg R.J., Shankland S.J., Okada N., Johnson R.J. & Couser W.G. (1997) Overexpression of Crry protects mesangial cells from complement- mediated injury. J Am Soc Nephrol 8, 223.
19. 19. Morgan B.P. (1992) Effects of the membrane attack complex of complement on nucleated cells. Curr Top Microbiol Immunol 178, 115.
20. 20. Nicholson-Wheller A. & Halperin J.A. (1993) Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 12, 244.
21. 21. Couser W.G. (1990) Mediation of immune glomerular injury. J Am Soc Nephrol 1, 13.
22. 22. He C., Alexander J.J., Lim A. & Quigg, R.J. (1997) Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris. Arch Biochem Biophys 341, 347.
23. 23. Quigg R.J., Lo C.F., Alexander J.J., Sneed A.E. & Moxley G. (1995) Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics 42, 362.
24. 24. Hughes T.R., Piddlesden S.J., Williams J.D., Harrison R.A. & Morgan B.P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284, 169.
25. 25. Schiller B., He C., Salant D.J., Lim A., Alexander J.J. & Quigg R.J. (1998) Inhibition of complement regulation is key to the pathogenesis of Heymann nephritis. J Exp Med 188, 1353.
26. 26. Abraha A., Morgan B.P. & Luzio J.P. (1988) The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits. Biochem J 251, 285.
27. 27. Harrison R.A. (1996). Handbook of Experimental Immunology (eds D.M. Weir, L.A. Herzenberg & C. Blackwell). Black well Science, Cambridge, MA.
28. 28. Würzner R., Nitze R. & Götze O. (1990) C7*9, a new frequent C7 allele detected by an allotype-specific monoclonal antibody. Complement Inflamm 7, 290.
29. 29. Jones J., Laffafian I. & Morgan B.P. ( 1990) Purification of C8 and C9 from rat serum. Complement Inflamm 7, 42.
30. 30. Sugita Y., Ito K., Shiozuka K. et al. (1994) Recombinant soluble CD59 inhibits reactive haemolysis with complement. Immunology 82, 34.
31. 31. Pangburn M.K. (1986) Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases. J Immunol 136, 2216.
32. 32. Zhang H., Yu J., Bajwa E., Morrison S.L. & Tomlinson S. (1999) Targeting of functional antibody-CD59 fusion proteins to a cell surface. J Clin Invest 103, 55.
33. 33. Hill J., Lindsay T.F., Ortiz F., Yeh C.G., Hechtman H.B. & Moore F.D. Jr (1992) Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Imnnmol 149, 1723.
34. 34. Xia W., Fearon D.T., Moore F.D. Jr, Schoen F.J., Ortiz F. & Kirkman R.L. (1992) Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplant Proc 24, 479.
35. 35. Christiansen D., Milland J., Thorley B.R., McKenzie I.F. & Loveland B.E. (1996) A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro. EM J Immunol 26, 578.
36. 36. Kim Y.-U., Kinoshita T., Molina H. et al. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181, 151.
37. 37. Quigg R.J., Kozono Y., Berthiaume D. et al. (1998) Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol 160, 4553.
38. 38. Quigg R.J., He C., Lim A. et al. (1998) Transgenic mice overexpressing the complement inhibitor Crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med 188, 1321.
39. 39. Couser W.G., Johnson R.J., Young B.A., Yeh C.G., Toth C.A. & Rudolph A.R. (1995) The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 5, 1888.
40. 40. Parker W., Bruno D., Holzknecht Z.E. & Platt J.L. (1994) Characterization and affinity isolation of xenoreactive human natural antibodies. J Imnumol 153, 3791.
41. 41. Weiser M.R., Williams J.P., Moore F.D. Jr et al. (1996) Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183, 2343.